Article
Combination of stem cell and gene therapy ameliorates symptoms in Huntington’s disease mice
26 Mar 2019
Abstract excerpt
Abstract Huntington’s disease (HD) is a dominantly inherited monogenetic disorder characterized by motor and cognitive dysfunction due to neurodegeneration. The disease is caused by the polyglutamine (polyQ) expansion at the 5′ terminal of the exon 1 of the huntingtin (HTT) gene, IT15, which results in the accumulation of mutant HTT (mHTT) aggregates in neurons and cell death. The monogenetic cause and the loss...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
